Remodeling of the tumor/tumor microenvironment ecosystem during KRAS G12C inhibitor clinical resistance in lung cancer

KRAS G12C inhibitors such as sotorasib and adagrasib are often effective in KRAS G12C–driven non–small cell lung cancer (NSCLC) patients. However, acquired resistance limits long-term patient survival. In this issue of the JCI, Tsai et al. present a comprehensive genetic analysis of multiple tumors...

Descripción completa

Detalles Bibliográficos
Autores principales: Manabe, Tadashi, Bivona, Trever G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843703/
https://www.ncbi.nlm.nih.gov/pubmed/35166243
http://dx.doi.org/10.1172/JCI156891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843703/
https://www.ncbi.nlm.nih.gov/pubmed/35166243
http://dx.doi.org/10.1172/JCI156891

Ejemplares similares